查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1787002

個人化醫療市場，規模，佔有率，趨勢，產業分析報告:各產品，各最終用途，各地區-2025～2034年市場預測

Personalized Medicine Market Size, Share, Trend, Industry Analysis Report By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Others), By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，個人化醫療市場規模預計到 2034 年將達到 1.3 兆美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

個人化醫療市場專注於利用基因、環境和生活方式數據來指導臨床決策，並根據每位患者的獨特特徵制定個人化治療方案。基因組定序、分子診斷和生物資訊學的快速發展徹底改變了傳統醫療保健，使預測、預防和精準幹預成為可能。生物標記引導療法的臨床整合正在重塑腫瘤學、神經病學和心臟病學領域的治療方案。對價值導向醫療的日益重視，加速了對標靶治療的需求，這些療法可以最大限度地減少副作用並改善療效。直接面向消費者的基因檢測的興起和患者意識的不斷增強，正在擴大獲得客製化健康和預防策略的管道。

製藥公司正在投資生物標記發現和伴隨診斷，以優化臨床檢測結果和監管審批效率。市場趨勢包括向多組學分析、人工智慧決策工具和個人化數位療法的轉變。將個人化照護模式整合到初級保健框架中，並利用電子健康記錄來支持臨床基因組數據整合，這些數據都蘊藏著機會。支付方對精準醫療報銷的興趣日益濃厚，這正在創造新的商業途徑。

專注於罕見疾病基因組學和分層醫療計劃的公私合作夥伴關係正在加強創新管道。診斷、治療和數據科學的融合正在釋放個人化醫療的全部潛力，使其成為現代醫療保健的核心支柱。個人化營養和以微生物學為重點的干預措施日益被接受，也預示著向整體健康管理的更廣泛轉變。隨著利害關係人整合臨床效用、技術能力和監管支持，以推動個人化醫療解決方案，個人化醫療市場預計將在未來幾年快速發展。

個人化醫療市場報告重點

依產品類型劃分，個人化營養與健康領域將在2024年佔據約33%的銷售額。消費者對預防醫學和生活方式相關疾病的認識不斷提高，推動了對客製化營養健康解決方案的需求。

依最終用途劃分，醫院領域將在2024年佔據最大佔有率。先進的基礎設施和廣泛的分子檢測平台使醫院成為實施精準醫療的關鍵樞紐。

受基因組技術、先進診斷技術和精準醫療在臨床環境中廣泛應用的推動，北美將在2024年佔40%的銷售額。

預計亞太地區個人化醫療市場在2025年至2034年間的複合年增長率將達到12.2%。人口密集國家對個人化醫療的需求快速增長、醫療保健支出的增加以及基因組服務管道的不斷擴大，正在推動市場擴張。

全球主要公司包括雅培（Abbott）、ASURAGEN, INC.、Biogen、Celera Diagnostics LLC.、Dako A/S、丹納赫集團（Cepheid, Inc.）、Decode Genetics, Inc.、Exact Sciences Corporation、Exagen Inc.、GE Healthcare、Genelex、Illcode Genetics, Inc.、Exact Sciences Corporation、Exagen Inc。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球個人化醫療市場洞察

  • 市場概述
  • 個人化醫療市場動態
    • 促進因素和機會
      • 慢性病和罕見病患病率不斷上升
      • 製藥和生技公司加大研發投入
    • 限制與挑戰
      • 高昂的開發和診斷成本
  • PESTEL分析
  • 個人化醫療市場用途趨勢
  • 價值鏈分析

第5章 全球個人化醫療市場:各產品

  • 主要調查結果
  • 簡介
  • 個人化醫療診斷
  • 個人化醫療治療
  • 個人化醫療
  • 個體化營養和健康

第6章 全球個人化醫療市場:各最終用途

  • 主要調查結果
  • 簡介
  • 醫院
  • 診斷中心
  • 研究·學術機構
  • 其他

第7章 全球個人化醫療市場:地區

  • 主要調查結果
  • 簡介
    • 個人化醫療市場評估:地區，2020～2034年
  • 北美
    • 北美:各產品，2020～2034年
    • 北美:各最終用途，2020～2034年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲:各產品，2020～2034年
    • 歐洲:各最終用途，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他的歐洲
  • 亞太地區
    • 亞太地區:各產品，2020～2034年
    • 亞太地區:各最終用途，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他的亞太地區
  • 中東·非洲
    • 中東·非洲:各產品，2020～2034年
    • 中東·非洲:各最終用途，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他的中東·非洲
  • 南美
    • 南美:各產品，2020～2034年
    • 南美:各最終用途，2020～2034年
    • 巴西
    • 阿根廷
    • 其他的南美

第8章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第9章 企業簡介

  • Abbott
  • ASURAGEN, INC.
  • Biogen
  • Celera Diagnostics LLC.
  • Dako A/S
  • Danaher Corporation(Cepheid, Inc.)
  • Decode Genetics, Inc.
  • Exact Sciences Corporation
  • Exagen Inc.
  • GE Healthcare
  • Genelex
  • Illumina, Inc.
  • Precision Biologics
  • QIAGEN
Product Code: PM5986

The personalized medicine market size is expected to reach USD 1,300.20 billion by 2034, according to a new study by Polaris Market Research. The report "Personalized Medicine Market Size, Share, Trend, Industry Analysis Report By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Others), By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The personalized medicine market focuses on tailoring medical treatment to the individual characteristics of each patient, using genetic, environmental, and lifestyle data to guide clinical decisions. Rapid advances in genomic sequencing, molecular diagnostics, and bioinformatics have transformed traditional healthcare by enabling predictive, preventive, and precisely targeted interventions. The integration of biomarker-based therapies into clinical practice is reshaping treatment protocols across oncology, neurology, and cardiology. Increasing emphasis on value-based care is accelerating demand for targeted drugs that minimize adverse effects and improve therapeutic outcomes. The growth in direct-to-consumer genetic testing and increasing patient awareness is expanding access to customized wellness and preventive strategies.

Pharmaceutical companies are investing in biomarker discovery and companion diagnostics to optimize clinical trial outcomes and regulatory approval efficiency. Market trends include a shift toward multi-omics profiling, AI-powered decision-making tools, and personalized digital therapeutics. Opportunities lie in integrating personalized care models into primary care frameworks and leveraging electronic health records to support clinical-genomic data convergence. Increasing interest from payers in covering precision medicine therapies is creating new commercial pathways.

Public-private partnerships focused on rare disease genomics and stratified medicine initiatives are enhancing innovation pipelines. The convergence of diagnostics, therapeutics, and data science is unlocking the full potential of personalized care, making it a central pillar of modern medicine. Growing acceptance of personalized nutrition and microbiome-focused interventions also signals a broader shift toward holistic health management. The personalized medicine market is expected to evolve rapidly in the coming years as stakeholders align clinical utility, technological capabilities, and regulatory support to advance individualized healthcare solutions.

Personalized Medicine Market Report Highlights

By product, the personalized nutrition & wellness segment accounted for ~33% of the revenue share in 2024. Growing consumer awareness about preventive healthcare and lifestyle-related diseases has increased the demand for tailored nutrition and wellness solutions.

Based on end use, the hospitals segment accounted for the largest share in 2024. Advanced infrastructure and broader access to molecular testing platforms make hospitals key centers for implementing precision medicine.

North America accounted for ~40% of the revenue share in 2024 due to high adoption of genomic technologies, advanced diagnostics, and precision therapeutics across clinical settings.

The personalized medicine market in Asia Pacific is expected to register a CAGR of 12.2% from 2025 to 2034, as surging demand for tailored healthcare in densely populated countries, rising healthcare spending, and growing access to genomic services are driving expansion.

A few global key players include Abbott; ASURAGEN, INC.; Biogen; Celera Diagnostics LLC.; Dako A/S; Danaher Corporation (Cepheid, Inc.); Decode Genetics, Inc.; Exact Sciences Corporation; Exagen Inc.; GE Healthcare; Genelex; Illumina, Inc.; Precision Biologics; and QIAGEN.

Polaris Market Research has segmented the personalized medicine market report on the basis of product, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Personalized Medicine Diagnostics

Genetic Testing

Direct-To-Consumer (DTC) Diagnostics

Others

Personalized Medicine Therapeutics

Pharmaceutical

Genomic Medicine

Medical Devices

Personalized Medical Care

Personalized Nutrition & Wellness

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Diagnostic Centers

Research & Academic Institutes

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Personalized Medicine Market Insights

  • 4.1. Personalized Medicine Market - Market Snapshot
  • 4.2. Personalized Medicine Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Chronic and Rare Diseases
      • 4.2.1.2. Increased Investment in R&D by Pharma and Biotech Firms
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High development and diagnostic costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Personalized Medicine Market Application Trends
  • 4.6. Value Chain Analysis

5. Global Personalized Medicine Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Personalized Medicine Diagnostics
    • 5.3.1. Global Personalized Medicine Market, by Personalized Medicine Diagnostics, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Genetic Testing
      • 5.3.2.1. Global Personalized Medicine Market, by Genetic Testing, by Region, 2020-2034 (USD Billion)
    • 5.3.3. Direct-To-Consumer (DTC) Diagnostics
      • 5.3.3.1. Global Personalized Medicine Market, by Direct-To-Consumer (DTC) Diagnostics, by Region, 2020-2034 (USD Billion)
    • 5.3.4. Others
      • 5.3.4.1. Global Personalized Medicine Market, by Others, by Region, 2020-2034 (USD Billion)
  • 5.4. Personalized Medicine Therapeutics
    • 5.4.1. Global Personalized Medicine Market, by Personalized Medicine Therapeutics, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Pharmaceutical
      • 5.4.2.1. Global Personalized Medicine Market, by Pharmaceutical, by Region, 2020-2034 (USD Billion)
    • 5.4.3. Genomic Medicine
      • 5.4.3.1. Global Personalized Medicine Market, by Genomic Medicine, by Region, 2020-2034 (USD Billion)
    • 5.4.4. Medical Devices
      • 5.4.4.1. Global Personalized Medicine Market, by Medical Devices, by Region, 2020-2034 (USD Billion)
  • 5.5. Personalized Medical Care
    • 5.5.1. Global Personalized Medicine Market, by Personalized Medical Care, by Region, 2020-2034 (USD Billion)
  • 5.6. Personalized Nutrition & Wellness
    • 5.6.1. Global Personalized Medicine Market, by Others, by Personalized Nutrition & Wellness, 2020-2034 (USD Billion)

6. Global Personalized Medicine Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Global Personalized Medicine Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 6.4. Diagnostic Centers
    • 6.4.1. Global Personalized Medicine Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
  • 6.5. Research & Academic Institutes
    • 6.5.1. Global Personalized Medicine Market, by Research & Academic Institutes, by Region, 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Personalized Medicine Market, by Othersr, by Region, 2020-2034 (USD Billion)

7. Global Personalized Medicine Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Personalized Medicine Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Personalized Medicine Market - North America
    • 7.3.1. North America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
    • 7.3.2. North America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.3. Personalized Medicine Market - U.S.
      • 7.3.3.1. U.S.: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.4. Personalized Medicine Market - Canada
      • 7.3.4.1. Canada: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.5. Personalized Medicine Market - Mexico
      • 7.3.5.1. Mexico: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.3.5.2. Mexico: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • 7.4. Personalized Medicine Market - Europe
    • 7.4.1. Europe: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.3. Personalized Medicine Market - UK
      • 7.4.3.1. UK: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.4. Personalized Medicine Market - France
      • 7.4.4.1. France: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.5. Personalized Medicine Market - Germany
      • 7.4.5.1. Germany: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.6. Personalized Medicine Market - Italy
      • 7.4.6.1. Italy: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.7. Personalized Medicine Market - Spain
      • 7.4.7.1. Spain: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.8. Personalized Medicine Market - Netherlands
      • 7.4.8.1. Netherlands: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.9. Personalized Medicine Market - Russia
      • 7.4.9.1. Russia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.10. Personalized Medicine Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • 7.5. Personalized Medicine Market - Asia Pacific
    • 7.5.1. Asia Pacific: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.3. Personalized Medicine Market - China
      • 7.5.3.1. China: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.4. Personalized Medicine Market - India
      • 7.5.4.1. India: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.5. Personalized Medicine Market - Malaysia
      • 7.5.5.1. Malaysia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.6. Personalized Medicine Market - Japan
      • 7.5.6.1. Japan: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.7. Personalized Medicine Market - Indonesia
      • 7.5.7.1. Indonesia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.8. Personalized Medicine Market - South Korea
      • 7.5.8.1. South Korea: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.9. Personalized Medicine Market - Australia
      • 7.5.9.1. Australia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.10. Personalized Medicine Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • 7.6. Personalized Medicine Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.3. Personalized Medicine Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.4. Personalized Medicine Market - UAE
      • 7.6.4.1. UAE: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.5. Personalized Medicine Market - Israel
      • 7.6.5.1. Israel: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.6. Personalized Medicine Market - South Africa
      • 7.6.6.1. South Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.7. Personalized Medicine Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • 7.7. Personalized Medicine Market - Latin America
    • 7.7.1. Latin America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.3. Personalized Medicine Market - Brazil
      • 7.7.3.1. Brazil: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.7.3.2. Brazil: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.4. Personalized Medicine Market - Argentina
      • 7.7.4.1. Argentina: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.7.4.2. Argentina: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.5. Personalized Medicine Market - Rest of Latin America
      • 7.7.5.1. Rest of Latin America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
      • 7.7.5.2. Rest of Latin America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. ASURAGEN, INC.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Biogen
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Celera Diagnostics LLC.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Dako A/S
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Danaher Corporation (Cepheid, Inc.)
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Decode Genetics, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Exact Sciences Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Exagen Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. GE Healthcare
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Genelex
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Illumina, Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Precision Biologics
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. QIAGEN
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development

List of Tables:

  • Table 1 Global Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 3 North America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 4 North America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 U.S.: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 6 U.S.: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 Canada: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 8 Canada: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 Mexico: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 10 Mexico: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 11 Europe: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 12 Europe: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 UK: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 14 UK: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 15 France: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 16 France: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Germany: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 18 Germany: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 Italy: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 20 Italy: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 Spain: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 22 Spain: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 23 Netherlands: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 24 Netherlands: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Russia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Russia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 27 Rest of Europe: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 28 Rest of Europe: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 Asia Pacific: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 30 Asia Pacific: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 China: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 32 China: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 India: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 34 India: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 35 Malaysia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 36 Malaysia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Japan: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Japan: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 39 Indonesia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 40 Indonesia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 South Korea: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 42 South Korea: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 Australia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 44 Australia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Rest of Asia Pacific: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 46 Rest of Asia Pacific: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 47 Middle East & Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 48 Middle East & Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Saudi Arabia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Saudi Arabia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 51 UAE: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 52 UAE: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 Israel: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 54 Israel: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 South Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 56 South Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 Rest of Middle East & Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 58 Rest of Middle East & Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 59 Latin America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 60 Latin America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Brazil: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Brazil: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 63 Argentina: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 64 Argentina: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Personalized Medicine Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Personalized Medicine Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by End Use
  • Figure 9. Global Personalized Medicine Market, by End Use, 2024 & 2034 (USD Billion)